|
1
|
Kotz EA, Anderson D and Thiers BH:
Cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol.
17:131–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neelis KJ, Schimmel EC, Vermeer MH, Senff
NJ, Willemze R and Noordijk EM: Low-dose palliative radiotherapy
for cutaneous B- and T-cell lymphomas. Int J Radiat Oncol Biol
Phys. 74:154–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Willemze R, Jaffe ES, Burg G, Cerroni L,
Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL,
Duncan LM, et al: WHO-EORTC classification for cutaneous lymphomas.
Blood. 105:3768–3785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang Y, Su MW, Jiang X and Zhou Y:
Evidence of an oncogenic role of aberrant TOX activation in
cutaneous T-cell lymphoma. Blood. 125:1435–1443. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sibbesen NA, Kopp KL, Litvinov IV, Jønson
L, Willerslev-Olsen A, Fredholm S, Petersen DL, Nastasi C,
Krejsgaard T, Lindahl LM, et al: Jak3, STAT3, and STAT5 inhibit
expression of miR-22, a novel tumor suppressor microRNA, in
cutaneous T-Cell lymphoma. Oncotarget. 6:20555–20569. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chou J, Provot S and Werb Z: GATA3 in
development and cancer differentiation: Cells GATA have it! J Cell
Physiol. 222:42–49. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang W, Wang Z, Luo Y, Zhong D, Luo Y and
Zhou D: GATA3 expression correlates with poor prognosis and
tumor-associated macrophage infiltration in peripheral T cell
lymphoma. Oncotarget. 7:65284–65294. 2016.PubMed/NCBI
|
|
8
|
Kari L, Loboda A, Nebozhyn M, Rook AH,
Vonderheid EC, Nichols C, Virok D, Chang C, Horng WH, Johnston J,
et al: Classification and prediction of survival in patients with
the leukemic phase of cutaneous T cell lymphoma. J Exp Med.
197:1477–1488. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Majewska E, Rola R, Barczewska M, Marquez
J, Albrecht J and Szeliga M: Transcription factor GATA3 expression
is induced by GLS2 overexpression in a glioblastoma cell line but
is GLS2-independent in patient-derived glioblastoma. J Physiol
Pharmacol. 68:209–214. 2017.PubMed/NCBI
|
|
10
|
Nawijn MC, Ferreira R, Dingjan GM, Kahre
O, Drabek D, Karis A, Grosveld F and Hendriks RW: Enforced
expression of GATA-3 during T cell development inhibits maturation
of CD8 single-positive cells and induces thymic lymphoma in
transgenic mice. J Immunol. 167:715–723. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gibson HM, Mishra A, Chan DV, Hake TS,
Porcu P and Wong HK: Impaired proteasome function activates GATA3
in T cells and upregulates CTLA-4: Relevance for Sézary syndrome. J
Invest Dermatol. 133:249–257. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng R and Blobel GA: GATA transcription
factors and cancer. Genes Cancer. 1:1178–1188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang XI, Luo Y, Zhao S, Chen Q, Jiang C,
Dai Y, Chen Y and Cao Z: Clinical significance and expression of
microRNA in diabetic patients with erectile dysfunction. Exp Ther
Med. 10:213–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia W, Wu Y, Zhang Q, Gao GE, Zhang C and
Xiang Y: Expression profile of circulating microRNAs as a promising
fingerprint for cervical cancer diagnosis and monitoring. Mol Clin
Oncol. 3:851–858. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Graziano A, Lo Monte G, Piva I, Caserta D,
Karner M, Engl B and Marci R: Diagnostic findings in adenomyosis: A
pictorial review on the major concerns. Eur Rev Med Pharmacol Sci.
19:1146–1154. 2015.PubMed/NCBI
|
|
16
|
Abe F, Kitadate A, Ikeda S, Yamashita J,
Nakanishi H, Takahashi N, Asaka C, Teshima K, Miyagaki T, Sugaya M
and Tagawa H: Histone deacetylase inhibitors inhibit metastasis by
restoring a tumor suppressive microRNA-150 in advanced cutaneous
T-cell lymphoma. Oncotarget. 8:7572–7585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McGirt LY, Baerenwald DA, Vonderheid EC
and Eischen CM: Early changes in miRNA expression are predictive of
response to extracorporeal photopheresis in cutaneous T-cell
lymphoma. J Eur Acad Dermatol Venereol. 29:2269–2271. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Q, Zhang H, Shen X and Ju S: Serum
microRNA-135a-5p as an auxiliary diagnostic biomarker for
colorectal cancer. Ann Clin Biochem. 54:76–85. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Desgagné V, Guay SP, Guérin R, Corbin F,
Couture P, Lamarche B and Bouchard L: Variations in HDL-carried
miR-223 and miR-135a concentrations after consumption of dietary
trans fat are associated with changes in blood lipid and
inflammatory markers in healthy men-an exploratory study.
Epigenetics. 11:438–448. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin L, He Y, Xi BL, Zheng HC, Chen Q, Li
J, Hu Y, Ye MH, Chen P and Qu Y: MiR-135a suppresses calcification
in senescent VSMCs by regulating KLF4/STAT3 pathway. Curr Vasc
Pharmacol. 14:211–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi H, Ji Y, Zhang D, Liu Y and Fang P:
MiR-135a inhibits migration and invasion and regulates EMT-related
marker genes by targeting KLF8 in lung cancer cells. Biochem
Biophys Res Commun. 465:125–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Navarro A, Diaz T, Martinez A, Gaya A,
Pons A, Gel B, Codony C, Ferrer G, Martinez C, Montserrat E and
Monzo M: Regulation of JAK2 by miR-135a: Prognostic impact in
classic Hodgkin lymphoma. Blood. 114:2945–2951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nasser MI, Masood M, Wei W and Li X, Zhou
Y, Liu B, Li J and Li X: Cordycepin induces apoptosis in SGC-7901
cells through mitochondrial extrinsic phosphorylation of PI3K/Akt
by generating ROS. Int J Oncol. 50:911–919. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Woetmann A, Lovato P, Eriksen KW,
Krejsgaard T, Labuda T, Zhang Q, Mathiesen AM, Geisler C, Svejgaard
A, Wasik MA and Ødum N: Nonmalignant T cells stimulate growth of
T-cell lymphoma cells in the presence of bacterial toxins. Blood.
109:3325–3332. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Q, Xu J, Chai B, Liang A and Wang W:
Functional comparison of metallothioneins MTT1 and MTT2 from
Tetrahymena thermophila. Arch Biochem Biophys. 509:170–176. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stamm CL and Safrit MJ: Comparison of
significance tests for repeated measures ANOVA design. Res Q.
46:403–409. 1975.PubMed/NCBI
|
|
27
|
McGirt LY, Degesys CA, Johnson VE, Zic JA,
Zwerner JP and Eischen CM: TOX expression and role in CTCL. J Eur
Acad Dermatol Venereol. 30:1497–1502. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dulmage BO, Akilov O, Vu JR, Falo LD and
Geskin LJ: Dysregulation of the TOX-RUNX3 pathway in cutaneous
T-cell lymphoma. Oncotarget. 2015.
|
|
29
|
Ho IC, Tai TS and Pai SY: GATA3 and the
T-cell lineage: Essential functions before and after
T-helper-2-cell differentiation. Nat Rev Immunol. 9:125–135. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Williams AE, Moschos SA, Perry MM, Barnes
PJ and Lindsay MA: Maternally imprinted microRNAs are
differentially expressed during mouse and human lung development.
Dev Dyn. 236:572–580. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wienholds E and Plasterk RH: MicroRNA
function in animal development. FEBS Lett. 579:5911–5922. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li X, Yu Z, Li Y, Liu S, Gao C, Hou X, Yao
R and Cui L: The tumor suppressor miR-124 inhibits cell
proliferation by targeting STAT3 and functions as a prognostic
marker for postoperative NSCLC patients. Int J Oncol. 46:798–808.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: MicroRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khan AA, Betel D, Miller ML, Sander C,
Leslie CS and Marks DS: Transfection of small RNAs globally
perturbs gene regulation by endogenous microRNAs. Nat Biotechnol.
27:549–555. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin M, Tang S, Zhang C, Chen H, Huang W,
Liu Y and Zhang J: Euphorbia factor L2 induces apoptosis in A549
cells through the mitochondrial pathway. Acta Pharm Sin B. 7:59–64.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang JY, Lin MT, Tung HY, Tang SL, Yi T,
Zhang YZ, Tang YN, Zhao ZZ and Chen HB: Bruceine D induces
apoptosis in human chronic myeloid leukemia K562 cells via
mitochondrial pathway. Am J Cancer Res. 6:819–826. 2016.PubMed/NCBI
|
|
37
|
Zhou W, Bi X, Gao G and Sun L: miRNA-133b
and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling
pathway in human renal carcinoma cells. Biomed Pharmacother.
84:722–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
